Correlation Between Indaptus Therapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and SAB Biotherapeutics, you can compare the effects of market volatilities on Indaptus Therapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and SAB Biotherapeutics.
Diversification Opportunities for Indaptus Therapeutics and SAB Biotherapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Indaptus and SAB is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 246.06 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Indaptus Therapeutics is 19.08 times less risky than SAB Biotherapeutics. It trades about 0.01 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 6.91 in SAB Biotherapeutics on August 30, 2024 and sell it today you would lose (0.08) from holding SAB Biotherapeutics or give up 1.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 75.35% |
| Values | Daily Returns |
Indaptus Therapeutics vs. SAB Biotherapeutics
Performance |
| Timeline |
| Indaptus Therapeutics |
| SAB Biotherapeutics |
Indaptus Therapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Indaptus Therapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |